Obesity Paradox in Non Valvular Atrial Fibrillation Regarding Outcomes: Fact or Fiction

• Conditions: Obesity Paradox
• Interventions: Drug: Oral Anticoagulant

• Registration Number: NCT03904329
• Lead Sponsor: Assiut University

Brief Summary

Obesity paradox In patient with non valvular atrial fibrillation

Detailed Description

Study role of obesity in outcomes of anticoagulation in patients with non valvular atrial fibrillation

Study Timeline

• Study First Submitted: 2019-03-25
• Study First Submitted QC: 2019-04-03
• Study First Posted: 2019-04-05
• Study Start: 2020-10-01
• Status Verified: 2022-02
• Last Update Submitted: 2022-08-03
• Last Update Posted: 2022-08-04
• Primary Completion: 2023-08-01
• Study Completion: 2023-10-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

• patients presented with non valvular AF
• patients on oral anticoagulant

Exclusion Criteria

• valvular AF
• Mental illness
• History of cerebrovascular stroke
• history of bleeding tendency
• history of Chronic renal failure

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Obese Patients with non valvular AF	Oral Anticoagulant	Obese Patients with non valvular AF using oral anti coagulants

Primary Outcome Measures

Name	Time	Method
Correlation between obesity and outcomes in non valvular atrial fibrillation	Sixth months	To study effect of obesity in outcomes of non valvular atrial fibrillation regarding the effect of obesity in the outcome of anticoagulants

Trial Locations

Locations (1)

Kristen amir; 🇪🇬 Assiut, Egypt